Jonathan Wolleben
Stock Analyst at JMP Securities
(1.4)
# 1655
Out of 5,343 analysts
206
Total ratings
43.30%
Success rate
9.86%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CLSD Clearside Biomedical | Reiterates: Market Outperform | 5 5 | 0.84 | 495.24% | 11 | May 16, 2025 | |
MIRM Mirum Pharmaceutical... | Maintains: Market Outperform | 74 76 | 44.16 | 72.1% | 10 | May 9, 2025 | |
MDGL Madrigal Pharmaceuti... | Reiterates: Market Outperform | 443 443 | 276.87 | 60% | 12 | Apr 24, 2025 | |
MBX MBX Biosciences | Initiates Coverage On: Market Outperform | 38 | 12.06 | 215.09% | 1 | Apr 10, 2025 | |
ALT Altimmune | Reiterates: Market Outperform | 25 25 | 5.75 | 334.78% | 12 | Apr 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 19 19 | 11.88 | 59.93% | 3 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 21 19 | 6.02 | 215.61% | 7 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 15 15 | n/a | n/a | 2 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 61 61 | 45.88 | 32.96% | 11 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 22 19 | 7.33 | 159.21% | 17 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 10 10 | 8.67 | 15.34% | 13 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 55 55 | 16.25 | 238.46% | 11 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 10.52 | 71.1% | 7 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 26 26 | 3.98 | 553.27% | 2 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 91 87 | 24.75 | 251.52% | 8 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 92 91 | 30.43 | 199.05% | 14 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 75 75 | 62.83 | 19.37% | 2 | Dec 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 9 9 | 2.96 | 204.05% | 8 | Dec 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 55 50 | 38.59 | 29.57% | 1 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 90 90 | 74.12 | 21.42% | 1 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 1.69 | 373.37% | 6 | Dec 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 3 3 | n/a | n/a | 7 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Accumulate | 420 485 | 649.26 | -25.3% | 1 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 3 3 | 0.33 | 809.09% | 6 | Sep 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 48 32 | 3.42 | 835.67% | 8 | Aug 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 25 25 | 1.96 | 1175.51% | 11 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 0.33 | 2324.24% | 11 | Apr 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 24 | 26.36 | -8.95% | 1 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | May 25, 2021 |